Logos Global Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
2,200,000
-100,000
| -4% | -$928K | 2.26% | 12 |
|
|
2025
Q1 | $16.9M | Sell |
2,300,000
-1,200,000
| -34% | -$8.8M | 3% | 14 |
|
|
2024
Q4 | $29.9M | Hold |
3,500,000
| – | – | 3.5% | 10 |
|
|
2024
Q3 | $30.5M | Sell |
3,500,000
-1,650,000
| -32% | -$14.4M | 3.29% | 10 |
|
|
2024
Q2 | $35.2M | Sell |
5,150,000
-661,436
| -11% | -$4.52M | 2.83% | 7 |
|
|
2024
Q1 | $52M | Buy |
5,811,436
+1,811,436
| +45% | +$16.2M | 4.21% | 4 |
|
|
2023
Q4 | $17.8M | Buy |
+4,000,000
| New | +$17.8M | 1.67% | 16 |
|